Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

ILLUMINA, INC.

(ILMN)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur ILLUMINA, INC.
20:41Flagship Pioneering taps former FDA chief Hahn to head new cancer diagnostic firm
06/12Illumina's Grail Subsidiary to Provide Early Cancer Detection Test For Alignment Health..
03/12Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LL..
25/11Vitrolife To Distribute Genomic Testing Kits In Asia Pacific Region
24/11INSIDER SELL : Illumina
17/11Illumina and Sequoia Capital China Select First Startups to join Genomics Incubator in ..
17/11Illumina and Sequoia Capital China Select First Startups to join Genomics Incubator in ..
17/11EU Expected to Raise Objections to Illumina's Completed $8 Billion Grail Purchase
16/11INSIDER SELL : Illumina
16/11Illumina, Genetic Alliance Launch $120 Million Program Expanding Genome Sequencing Acce..
16/11Illumina defends Grail deal; expects EU formal objections on Wednesday
16/11Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity ..
05/11INSIDER SELL : Illumina
04/11Illumina Posts Higher Q3 Earnings, Revenue -- Stock Up
04/11Earnings Flash (ILMN) ILLUMINA Reports Q3 EPS $1.45, vs. Street Est of $1.22
04/11Earnings Flash (ILMN) ILLUMINA Reports Q3 Revenue $1.11B, vs. Street Est of $1.045B
04/11GUIDANCE : (ILMN) ILLUMINA Forecasts Fiscal Year 2021 EPS Range $5.50 - $5.60
04/11ILLUMINA : Q3 Earnings Snapshot
04/11Illumina Reports Financial Results for Third Quarter of Fiscal Year 2021 Raises Fiscal ..
04/11Illumina, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Oct..
04/11Illumina Reports Financial Results for Third Quarter of Fiscal Year 2021
04/11Illumina, Inc. Provides Earnings Guidance for the Fiscal Year 2021
03/11Illumina Supports Canada's Nationwide COVID-19 Genome Sequencing Initiative
03/11Illumina Supports Canada's Nationwide Covid-19 Genome Sequencing Initiative
29/10EU Orders Illumina, GRAIL to Operate Separately Until Merger Investigation Ends
29/10EU orders Illumina to keep Grail a separate company
29/10GRAIL AUDITED CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR THE YEARS ENDED DECEMBER ..
29/10ILLUMINA, INC. Completion of Acquisition or Disposition of Assets, Financial Statement..
28/10INSIDER SELL : Illumina
27/10Illumina Supports Israel's National Program to Accelerate Diagnoses of Critically-Ill N..
26/10INSIDER SELL : Illumina
22/10INSIDER SELL : Illumina
21/10ILLUMINA : to Host Inaugural ESG Investor Event on Tuesday, November 16, 2021
20/10Earnings season, bitcoin and the metaverse
20/10ANALYST RECOMMENDATIONS : BHP Group, Cloudflare, Tesla, Microsoft, Target...
15/10INSIDER SELL : Illumina
15/10ILLUMINA : Ragusa succeeds Hans Bishop, who will continue to serve as Advisor to the CEO t..
15/10Illumina, Inc. Announces Executive Changes
15/10ILLUMINA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
15/10ILLUMINA : Appoints Bob Ragusa as GRAIL's CEO
13/10ILLUMINA : to Announce Third Quarter 2021 Financial Results on Thursday, November 4, 2021
12/10ILLUMINA : European Commission To Make Decision On Illumina's GRAIL Acquisition By Februar..
12/10ILLUMINA : EU antitrust regulators resume Illumina, Grail probe, decision due by Feb. 4
30/09ILLUMINA : Expands Genomics Operations to Colombia, Mexico
30/09ILLUMINA : Expands Presence in Latin America
30/09Illumina Expands Presence in Latin America
27/09ILLUMINA : Says Genetic Testing Leads to Early Diagnosis of Genetic Conditions in Newborns..
27/09ILLUMINA : Randomized trial demonstrates whole-genome sequencing leads to precision care f..
27/09Randomized Trial Demonstrates Whole-Genome Sequencing Leads to Precision Care for Criti..
23/09INSIDER SELL : Illumina
23/09VC DAILY : Biotechs Seek New Skill Set From Scientists Entering Field
22/09ILLUMINA : EU Court ruling on Altice provides boost for antitrust regulators
21/09ILLUMINA : To Discuss EU-Suggested Tweaks To Grail Acquisition
20/09Illumina expects EU order to keep Grail a separate company
20/09ILLUMINA : says it had expected EU hold order on Grail
20/09ILLUMINA : European Commission Sends Statement of Objections Over GRAIL's Acquisition by I..
20/09ILLUMINA : expects EU order to keep Grail a separate company
20/09Illumina Reaffirms Commitment to the National Project of Bio Big Data in Korea
15/09Big Tech's little mergers draw more U.S. antitrust scrutiny
15/09ILLUMINA : Accelerator Invests in Seven Genomics Startups for Third Global Cycle
15/09FTC staff to present findings on Big Tech's smaller acquisitions
13/09UK NHS to Launch First Trial of Grail's Cancer-Detection Test
13/09ILLUMINA : Britain begins world's largest trial of blood test for 50 types of cancer
09/09Illumina Sets Net Zero Global GHG Emissions Target
09/09ILLUMINA : Commits to Net Zero Global Greenhouse Gas Emissions by 2050
09/09INSIDER SELL : Illumina
07/09Illumina, Merck to Collaborate Over Diagnostic Tests For Cancer Mutations
07/09Illumina, Inc Partners with Merck to Develop and Commercialize Companion Diagnostic and..
02/09ILLUMINA : U.S. lawmakers question FTC's efforts to stop Illumina's deal for Grail
30/08ILLUMINA : To Webcast Upcoming Investor Conference
24/08ILLUMINA : FTC urges judge to unwind $7.1 billion Illumina-Grail merger
23/08ILLUMINA : INVESTOR ALERT. An Investor Investigation Is Underway Regarding Illumina's Clos..
20/08ILLUMINA : European Commission to Open Probe Into Illumina's Premature Closing of Grail Ac..
20/08UE investiga decisión de Illumina de cerrar compra de Grail pese a dudas competencia
20/08ILLUMINA : EU regulators to investigate Illumina's completion of Grail deal
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur ILLUMINA, INC.